Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT01406860
Eligibility Criteria:
Inclusion Criteria:
* 18 years old to 65 years old, diagnosis of primary headache
Exclusion Criteria:
* Allergy to study medications, pregnant, breast-feeding, prisoners, non-english speaking, not eligible to receive droperidol based on ED protocol (see below), patients in whom head trauma, infection, vascular disorders, and disorders of facial or cranial structures are suspected
ED Droperidol Protocol
Droperidol must NOT be used in patients with any of the following:
* Known or suspected QT prolongation, including congenital long QT syndrome
* Cardiac Disease \[cardiomyopathy, congestive heart failure, hypertension, ischemic heart disease, myocardial infarction, bradycardia (\< 50 bpm)\]
* History of the following:
* Renal failure
* Cerebrovascular disease
* Diabetes or hypoglycemia
* Alcoholism/alcohol abuse
* Pituitary insufficiency
* Hypothyroidism
* Hypothermia
* Anorexia
* Advanced age (\>65 yrs)
* Use of the following medications: digoxin, benzodiazepine, diuretics, IV opiates, or other medications known to prolong the QTc interval.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT01406860
Study Brief:
Protocol Section:
NCT01406860